Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$217K Sell
1,250
-165
-12% -$30K 0.19% 158
2023
Q2
$244K Sell
1,415
-71
-5% -$12.3K 0.2% 133
2023
Q1
$247K Sell
1,486
-94
-6% -$15.4K 0.19% 160
2022
Q4
$232K Buy
1,580
+21
+1% +$3.11K 0.19% 149
2022
Q3
$231K Buy
1,559
+68
+5% +$11.4K 0.2% 149
2022
Q2
$256K Buy
1,491
+252
+20% +$43.6K 0.22% 110
2022
Q1
$234K Buy
1,239
+114
+10% +$22.5K 0.2% 171
2021
Q4
$275K Buy
+1,125
New +$246K 0.2% 142

Other funds holding ZTS

Syntax Advisors's ZTS Position: Q3 2023 in Review

Syntax Advisors reduced its Zoetis (ZTS) stake by 12% in Q3 2023, selling an estimated $30K and leaving 1,250 shares worth $217K. The position accounts for 0.19% of the portfolio, ranked #158.

Syntax Advisors first reported a position in ZTS in Q4 2021 and has held it in 8 quarters since. The position peaked at $275K in Q4 2021. 1,628 funds tracked by Wall St. Rank hold ZTS as of Q3 2023.

  • Syntax Advisors held 1,250 shares of Zoetis worth $217K as of Q3 2023.
  • Syntax Advisors sold 165 Zoetis shares in Q3 2023, an estimated $30K.
  • Zoetis made up 0.19% of Syntax Advisors's portfolio in Q3 2023, its #158 holding.
  • Syntax Advisors first reported a position in Zoetis in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Zoetis position peaked at $275K in Q4 2021.
  • 1,628 funds tracked by Wall St. Rank held Zoetis as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.